218 related articles for article (PubMed ID: 37047623)
1. Src-FAK Signaling Mediates Interleukin 6-Induced HCT116 Colorectal Cancer Epithelial-Mesenchymal Transition.
Huang YH; Chen HK; Hsu YF; Chen HC; Chuang CH; Huang SW; Hsu MJ
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047623
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells.
Huang YH; Yang HY; Huang SW; Ou G; Hsu YF; Hsu MJ
PLoS One; 2016; 11(7):e0158839. PubMed ID: 27383632
[TBL] [Abstract][Full Text] [Related]
3. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
5. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
6. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
Miao JW; Liu LJ; Huang J
Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
[TBL] [Abstract][Full Text] [Related]
8. Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.
Yuan H; Meng X; Guo W; Cai P; Li W; Li Q; Wang W; Sun Y; Xu Q; Gu Y
Neoplasia; 2015 May; 17(5):410-20. PubMed ID: 26025664
[TBL] [Abstract][Full Text] [Related]
9. Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness.
Franke FC; Slusarenko BO; Engleitner T; Johannes W; Laschinger M; Rad R; Nitsche U; Janssen KP
Int J Cancer; 2020 Sep; 147(6):1715-1731. PubMed ID: 32147820
[TBL] [Abstract][Full Text] [Related]
10. TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.
Baquero P; Jiménez-Mora E; Santos A; Lasa M; Chiloeches A
Mol Carcinog; 2016 Nov; 55(11):1639-1654. PubMed ID: 26392228
[TBL] [Abstract][Full Text] [Related]
11. SphK1 modulates cell migration and EMT-related marker expression by regulating the expression of p-FAK in colorectal cancer cells.
Xu CY; Liu SQ; Qin MB; Zhuge CF; Qin L; Qin N; Lai MY; Huang JA
Int J Mol Med; 2017 May; 39(5):1277-1284. PubMed ID: 28405684
[TBL] [Abstract][Full Text] [Related]
12. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells.
Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H
Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470
[TBL] [Abstract][Full Text] [Related]
13. Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol.
Buhrmann C; Yazdi M; Popper B; Kunnumakkara AB; Aggarwal BB; Shakibaei M
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917533
[TBL] [Abstract][Full Text] [Related]
14. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer.
Wang H; Wang HS; Zhou BH; Li CL; Zhang F; Wang XF; Zhang G; Bu XZ; Cai SH; Du J
PLoS One; 2013; 8(2):e56664. PubMed ID: 23431386
[TBL] [Abstract][Full Text] [Related]
16. TNF-α-inducing protein of Helicobacter pylori induces epithelial-mesenchymal transition (EMT) in gastric cancer cells through activation of IL-6/STAT3 signaling pathway.
Chen G; Tang N; Wang C; Xiao L; Yu M; Zhao L; Cai H; Han L; Xie C; Zhang Y
Biochem Biophys Res Commun; 2017 Mar; 484(2):311-317. PubMed ID: 28130110
[TBL] [Abstract][Full Text] [Related]
17. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
[TBL] [Abstract][Full Text] [Related]
18. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G
Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621
[TBL] [Abstract][Full Text] [Related]
19. The effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitro.
Huang C; Yang G; Jiang T; Zhu G; Li H; Qiu Z
Neoplasma; 2011; 58(5):396-405. PubMed ID: 21744993
[TBL] [Abstract][Full Text] [Related]
20. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
